RhumbLine Advisers’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61M | Buy |
|
|||||
|
2025
Q1 | $2.83M | Buy |
|
|||||
|
2024
Q4 | $2.34M | Buy |
|
|||||
|
2024
Q3 | $1.52M | Sell |
|
|||||
|
2024
Q2 | $1.56M | Buy |
|
|||||
|
2024
Q1 | $1.24M | Buy |
|
|||||
|
2023
Q4 | $345K | Buy |
|
|||||
|
2023
Q3 | $422K | Buy |
|
|||||
|
2023
Q2 | $749K | Buy |
|
|||||
|
2023
Q1 | $596K | Buy |
|
|||||
|
2022
Q4 | $790K | Buy |
|
|||||
|
2022
Q3 | $854K | Buy |
|
|||||
|
2022
Q2 | $881K | Buy |
|
|||||
|
2022
Q1 | $681K | Sell |
|
|||||
|
2021
Q4 | $738K | Buy |
|
|||||
|
2021
Q3 | $850K | Buy |
|
|||||
|
2021
Q2 | $936K | Buy |
|
|||||
|
2021
Q1 | $582K | Buy |
|
|||||
|
2020
Q4 | $565K | Buy |
|
|||||
|
2020
Q3 | $497K | Buy |
|
|||||
|
2020
Q2 | $334K | Buy |
|
|||||
|
2020
Q1 | $294K | Buy |
|